Photo taken fro Christopher Melani/X
Jun 23, 2024, 14:07
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma
Mark Roschewski, Senior Clinician in the Lymphoid Malignancies Branch at the National Cancer Institute, shared a post on X:
“Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma | New England Journal of Medicine
Concept by Wyndham Wilson, pre-clinical rationale by Lou Staudt, and study led by Christopher Melani.
Thanks to all patients.”
Read further.
Source: Mark Roschewski/X